These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

903 related articles for article (PubMed ID: 28513534)

  • 1. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.
    Macedo B; Cordeiro Y
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid-liquid phase separation and fibrillation of the prion protein modulated by a high-affinity DNA aptamer.
    Matos CO; Passos YM; do Amaral MJ; Macedo B; Tempone MH; Bezerra OCL; Moraes MO; Almeida MS; Weber G; Missailidis S; Silva JL; Uversky VN; Pinheiro AS; Cordeiro Y
    FASEB J; 2020 Jan; 34(1):365-385. PubMed ID: 31914616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA aptamers that bind to PrP(C) and not PrP(Sc) show sequence and structure specificity.
    Takemura K; Wang P; Vorberg I; Surewicz W; Priola SA; Kanthasamy A; Pottathil R; Chen SG; Sreevatsan S
    Exp Biol Med (Maywood); 2006 Feb; 231(2):204-14. PubMed ID: 16446497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a novel in vitro selection technique to isolate and characterise high affinity DNA aptamers binding mammalian prion proteins.
    Bibby DF; Gill AC; Kirby L; Farquhar CF; Bruce ME; Garson JA
    J Virol Methods; 2008 Jul; 151(1):107-15. PubMed ID: 18433888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of aptamers for amyloid beta-protein, the causative agent of Alzheimer's disease.
    Rahimi F; Bitan G
    J Vis Exp; 2010 May; (39):. PubMed ID: 20616783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast, reversible interaction of prion protein with RNA aptamers containing specific sequence patterns.
    Mercey R; Lantier I; Maurel MC; Grosclaude J; Lantier F; Marc D
    Arch Virol; 2006 Nov; 151(11):2197-214. PubMed ID: 16799875
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advancements in complex target systematic evolution of ligands by exponential enrichment].
    Wu Z; Xue S; Yang Y
    Se Pu; 2018 Oct; 36(10):947-951. PubMed ID: 30378352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamers to explore prion protein interactions with nucleic acids.
    Marc D
    Front Biosci (Landmark Ed); 2010 Jan; 15(2):550-63. PubMed ID: 20036833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in SELEX and application of aptamers in the central nervous system.
    Yang Y; Yang D; Schluesener HJ; Zhang Z
    Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
    Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
    Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection and characterization of DNA aptamers against PrP(Sc).
    Wang P; Hatcher KL; Bartz JC; Chen SG; Skinner P; Richt J; Liu H; Sreevatsan S
    Exp Biol Med (Maywood); 2011 Apr; 236(4):466-76. PubMed ID: 21444369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Specific Aptamers.
    Liu S; Suzuki Y; Inui M
    Methods Mol Biol; 2018; 1868():113-121. PubMed ID: 30244458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple method for eliminating fixed-region interference of aptamer binding during SELEX.
    Ouellet E; Lagally ET; Cheung KC; Haynes CA
    Biotechnol Bioeng; 2014 Nov; 111(11):2265-79. PubMed ID: 24895227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-SELEX: in vitro selection of synthetic small specific ligands.
    Dickinson H; Lukasser M; Mayer G; Hüttenhofer A
    Methods Mol Biol; 2015; 1296():213-24. PubMed ID: 25791604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficient screening for 8-oxoguanine DNA glycosylase binding aptamers via capillary electrophoresis].
    Han S; Zhao L; Yang G; Qu F
    Se Pu; 2021 Jul; 39(7):721-729. PubMed ID: 34227370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
    Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
    Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A computational study of alternate SELEX.
    Seo YJ; Nilsen-Hamilton M; Levine HA
    Bull Math Biol; 2014 Jul; 76(7):1455-521. PubMed ID: 24878869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.